| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |